Synergistic effect of venetoclax and teglicar in multiple myeloma cell lines
Multiple myeloma is a hematological malignancy characterized by the clonal proliferation of plasma cells. Recent advancements in treatment strategies have led to a significant shift in the management of this malignancy. Venetoclax, an apoptosis inducer, has emerged as a promising therapeutic option...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Pensoft Publishers,
2024-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|